Bruno M. L. Giannetti
Chief Operating Officer presso Pharming Intellectual Property BV
Profilo
Bruno M.
L.
Giannetti is the founder of CRM Pharmaberatung GmbH, CRM clinical trials GmbH.
He is currently the Chief Operations Officer at Pharming Intellectual Property BV.
Previously, he served as the President & Chief Executive Officer at Verigen AG, Chief Executive Officer at AM-Pharma BV, Head-Clinical Research at Madaus GmbH, and Chief Operations Officer at Pharming Group NV.
He also worked as the Vice President-Marketing & Medical Information at Immuno AG.
Dr. Giannetti holds a doctorate degree from the University of Bonn.
Posizioni attive di Bruno M. L. Giannetti
Società | Posizione | Inizio |
---|---|---|
Pharming Intellectual Property BV
Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Part of Pharming Group NV, Pharming Intellectual Property BV manufactures milking equipment. The private company is based in Leiden, Netherlands. The CEO of the Dutch company is Sijmen de Vries. | Chief Operating Officer | - |
Precedenti posizioni note di Bruno M. L. Giannetti
Società | Posizione | Fine |
---|---|---|
CRM Pharmaberatung GmbH | Founder | 31/10/2013 |
Immuno AG | Sales & Marketing | 09/12/2010 |
CRM clinical trials GmbH
CRM clinical trials GmbH Miscellaneous Commercial ServicesCommercial Services Part of hVIVO PLC, CRM clinical trials GmbH is a German company that provides clinical research and clinical trials management services. The private company is based in Rheinbach, Germany. The company was founded by Bruno M. L. Giannetti. CRM clinical trials was acquired by Venn Life Sciences Holdings Plc on January 13, 2014 for $0.83 million. | Founder | - |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Chief Executive Officer | - |
Madaus GmbH
Madaus GmbH Pharmaceuticals: MajorHealth Technology MADAUS GmbH manufactures pharmaceutical products. It provides medicines of plant origin together with products for 'Natural Prevention'. The firm offers products to treat the fundamental causes of disease, not merely the symptoms, and thereby to prevent diseases from occurring or at least from becoming chronic. The company was founded in 1919 by Gerhard Madaus, Friedemund Madaus and Hans Madaus and is headquartered in Cologne, Germany. | Chief Tech/Sci/R&D Officer | - |
Formazione di Bruno M. L. Giannetti
University of Bonn | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
PHARMING GROUP N.V. | Health Technology |
Aziende private | 7 |
---|---|
Madaus GmbH
Madaus GmbH Pharmaceuticals: MajorHealth Technology MADAUS GmbH manufactures pharmaceutical products. It provides medicines of plant origin together with products for 'Natural Prevention'. The firm offers products to treat the fundamental causes of disease, not merely the symptoms, and thereby to prevent diseases from occurring or at least from becoming chronic. The company was founded in 1919 by Gerhard Madaus, Friedemund Madaus and Hans Madaus and is headquartered in Cologne, Germany. | Health Technology |
Verigen AG
Verigen AG Miscellaneous Commercial ServicesCommercial Services Verigen specializes in tissue engineering. Its cartilage repair technology involves harvesting knee cartilage cells that are cultivated in a laboratory before being transplanted into the knee. The operation is invasive and shorter than conventional treatment, with concomitant cost savings and outcomes | Commercial Services |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Health Technology |
Immuno AG | |
CRM Pharmaberatung GmbH | |
CRM clinical trials GmbH
CRM clinical trials GmbH Miscellaneous Commercial ServicesCommercial Services Part of hVIVO PLC, CRM clinical trials GmbH is a German company that provides clinical research and clinical trials management services. The private company is based in Rheinbach, Germany. The company was founded by Bruno M. L. Giannetti. CRM clinical trials was acquired by Venn Life Sciences Holdings Plc on January 13, 2014 for $0.83 million. | Commercial Services |
Pharming Intellectual Property BV
Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Part of Pharming Group NV, Pharming Intellectual Property BV manufactures milking equipment. The private company is based in Leiden, Netherlands. The CEO of the Dutch company is Sijmen de Vries. | Producer Manufacturing |
- Borsa valori
- Insiders
- Bruno M. L. Giannetti